FDA OKs first new sunscreen ingredient in more than 25 years

Article excerpt

The FDA approved bemotrizinol, the first new sunscreen ingredient in over 25 years, marking a significant advancement in sun protection technology. The approval comes after decades of regulatory scrutiny and represents a breakthrough for manufacturers seeking alternatives to existing UV-blocking compounds. Bemotrizinol offers enhanced protection against UVA rays, addressing a long-standing gap in sunscreen formulations. The ingredient's clearance removes a major barrier that had kept the American sunscreen market largely stagnant while other countries introduced newer protective agents. Consumer products featuring bemotrizinol could reach shelves within months, potentially reshaping the competitive landscape of a multi-billion-dollar skincare industry.